{"count": 87, "results": [{"_id": "40852348", "pmid": 40852348, "title": "Role of Metformin in Preeclampsia: A Systematic Review.", "journal": "J Obstet Gynaecol India", "authors": ["Anuja M", "Arthy M", "Jha N", "Ashok MV", "Jha AK", "Sivaranjani P"], "date": "2025-08-01T00:00:00Z", "doi": "10.1007/s13224-025-02194-6", "meta_date_publication": "2025 Aug", "meta_volume": "75", "meta_issue": "4", "meta_pages": "282-289", "score": 50277.926, "text_hl": "Role of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ in @<m>DISEASE_Pre_Eclampsia</m> @DISEASE_MESH:D011225 @@@Preeclampsia@@@: A Systematic Review.", "citations": {"NLM": "Anuja M, Arthy M, Jha N, Ashok MV, Jha AK, Sivaranjani P. Role of Metformin in Preeclampsia: A Systematic Review. J Obstet Gynaecol India. 2025 Aug;75(4):282-289. PMID: 40852348", "BibTeX": "@article{40852348, title={Role of Metformin in Preeclampsia: A Systematic Review.}, author={Anuja M and Arthy M and Jha N and Ashok MV and Jha AK and Sivaranjani P}, journal={J Obstet Gynaecol India}, volume={75}, number={4}, pages={282-289}}"}}, {"_id": "34482529", "pmid": 34482529, "pmcid": "PMC8479018", "title": "Effects of Different Glucose-Lowering Measures on Maternal and Infant Outcomes in Pregnant Women with Gestational Diabetes: A Network Meta-analysis", "journal": "Diabetes Ther", "authors": ["Ouyang H", "Wu N"], "date": "2021-10-01T00:00:00Z", "doi": "10.1007/s13300-021-01142-7", "meta_date_publication": "2021 Oct", "meta_volume": "12", "meta_issue": "10", "meta_pages": "2715-2753", "score": 50275.246, "text_hl": "@<m>DISEASE_Pre_Eclampsia</m> @DISEASE_MESH:D011225 @@@Preeclampsia@@@ incidence in the diet and exercise groups was significantly lower than in the @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ (0.19, 95% CI 0.043-0.72) and @GENE_INS @GENE_3630 @@@insulin@@@ (0.15, 95% CI 0.032-0.52) groups. ", "citations": {"NLM": "Ouyang H, Wu N. Effects of Different Glucose-Lowering Measures on Maternal and Infant Outcomes in Pregnant Women with Gestational Diabetes: A Network Meta-analysis Diabetes Ther. 2021 Oct;12(10):2715-2753. PMID: 34482529", "BibTeX": "@article{34482529, title={Effects of Different Glucose-Lowering Measures on Maternal and Infant Outcomes in Pregnant Women with Gestational Diabetes: A Network Meta-analysis}, author={Ouyang H and Wu N}, journal={Diabetes Ther}, volume={12}, number={10}, pages={2715-2753}}"}}, {"_id": "33381040", "pmid": 33381040, "pmcid": "PMC7768035", "title": "Current Researches, Rationale, Plausibility, and Evidence Gaps on Metformin for the Management of Hypertensive Disorders of Pregnancy", "journal": "Front Pharmacol", "authors": ["Zhang Y", "Liu X", "Yang L", "Zou L"], "date": "2020-12-14T00:00:00Z", "doi": "10.3389/fphar.2020.596145", "meta_date_publication": "2020", "meta_volume": "11", "meta_issue": "", "meta_pages": "596145", "score": 50274.742, "text_hl": "Progress of Clinical Research on @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ in @<m>DISEASE_Pre_Eclampsia</m> @DISEASE_MESH:D011225 @@@Preeclampsia@@@", "citations": {"NLM": "Zhang Y, Liu X, Yang L, Zou L. Current Researches, Rationale, Plausibility, and Evidence Gaps on Metformin for the Management of Hypertensive Disorders of Pregnancy Front Pharmacol. 2020;11():596145. PMID: 33381040", "BibTeX": "@article{33381040, title={Current Researches, Rationale, Plausibility, and Evidence Gaps on Metformin for the Management of Hypertensive Disorders of Pregnancy}, author={Zhang Y and Liu X and Yang L and Zou L}, journal={Front Pharmacol}, volume={11}, pages={596145}}"}}, {"_id": "39351873", "pmid": 39351873, "title": "The effects of metformin on inflammation and apoptosis in rats with preeclampsia.", "journal": "J Hypertens", "authors": ["Chen Y", "Gao Z", "Wang L", "Duan R", "Hao H", "Jia R", "Ma H", "Gao R", "Su M", "Yang H", "Tu Z"], "date": "2024-10-02T00:00:00Z", "doi": "10.1097/HJH.0000000000003892", "meta_date_publication": "2024 Oct 2", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50267.84, "text_hl": "Our results indicate that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MET@@@ has huge therapeutic potential against @<m>DISEASE_Pre_Eclampsia</m> @DISEASE_MESH:D011225 @@@PE@@@.", "citations": {"NLM": "Chen Y, Gao Z, Wang L, Duan R, Hao H, Jia R, Ma H, Gao R, Su M, Yang H, Tu Z. The effects of metformin on inflammation and apoptosis in rats with preeclampsia. J Hypertens. 2024 Oct 2;():. PMID: 39351873", "BibTeX": "@article{39351873, title={The effects of metformin on inflammation and apoptosis in rats with preeclampsia.}, author={Chen Y and Gao Z and Wang L and Duan R and Hao H and Jia R and Ma H and Gao R and Su M and Yang H and Tu Z}, journal={J Hypertens}}"}}, {"_id": "37971596", "pmid": 37971596, "title": "Challenges in Conducting Clinical Trials for Preeclampsia.", "journal": "Curr Hypertens Rep", "authors": ["Bank TC", "Kline D", "Costantine MM"], "date": "2023-11-16T00:00:00Z", "doi": "10.1007/s11906-023-01276-y", "meta_date_publication": "2023 Nov 16", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50264.934, "text_hl": "Several medications, including @CHEMICAL_Aspirin @CHEMICAL_MESH:D001241 @@@aspirin@@@, @CHEMICAL_Pravastatin @CHEMICAL_MESH:D017035 @@@pravastatin@@@, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, and @CHEMICAL_Esomeprazole @CHEMICAL_MESH:D064098 @@@esomeprazole@@@, which are commonly used in non-pregnant populations, are now being investigated for @<m>DISEASE_Pre_Eclampsia</m> @DISEASE_MESH:D011225 @@@preeclampsia@@@ prevention. ", "citations": {"NLM": "Bank TC, Kline D, Costantine MM. Challenges in Conducting Clinical Trials for Preeclampsia. Curr Hypertens Rep. 2023 Nov 16;():. PMID: 37971596", "BibTeX": "@article{37971596, title={Challenges in Conducting Clinical Trials for Preeclampsia.}, author={Bank TC and Kline D and Costantine MM}, journal={Curr Hypertens Rep}}"}}, {"_id": "36329468", "pmid": 36329468, "pmcid": "PMC9635102", "title": "Systematic evaluation of the pre-eclampsia drugs, dietary supplements and biologicals pipeline using target product profiles", "journal": "BMC Med", "authors": ["McDougall ARA", "Hastie R", "Goldstein M", "Tuttle A", "Tong S", "Ammerdorffer A", "Gülmezoglu AM", "Vogel JP"], "date": "2022-11-04T00:00:00Z", "doi": "10.1186/s12916-022-02582-z", "meta_date_publication": "2022 Nov 4", "meta_volume": "20", "meta_issue": "1", "meta_pages": "393", "score": 50261.766, "text_hl": "A trial of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in 414 pregnant @SPECIES_9606 @@@women@@@ with a high risk of @<m>DISEASE_Pre_Eclampsia</m> @DISEASE_MESH:D011225 @@@pre-eclampsia@@@ in Qatar has been registered.", "citations": {"NLM": "McDougall ARA, Hastie R, Goldstein M, Tuttle A, Tong S, Ammerdorffer A, Gülmezoglu AM, Vogel JP. Systematic evaluation of the pre-eclampsia drugs, dietary supplements and biologicals pipeline using target product profiles BMC Med. 2022 Nov 4;20(1):393. PMID: 36329468", "BibTeX": "@article{36329468, title={Systematic evaluation of the pre-eclampsia drugs, dietary supplements and biologicals pipeline using target product profiles}, author={McDougall ARA and Hastie R and Goldstein M and Tuttle A and Tong S and Ammerdorffer A and Gülmezoglu AM and Vogel JP}, journal={BMC Med}, volume={20}, number={1}, pages={393}}"}}, {"_id": "37409227", "pmid": 37409227, "pmcid": "PMC10319127", "title": "Lights and shadows on the use of metformin in pregnancy: from the preconception phase to breastfeeding and beyond", "journal": "Front Endocrinol (Lausanne)", "authors": ["Tosti G", "Barberio A", "Tartaglione L", "Rizzi A", "Di Leo M", "Viti L", "Sirico A", "De Carolis S", "Pontecorvi A", "Lanzone A", "Pitocco D"], "date": "2023-06-20T00:00:00Z", "doi": "10.3389/fendo.2023.1176623", "meta_date_publication": "2023", "meta_volume": "14", "meta_issue": "", "meta_pages": "1176623", "score": 50261.52, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ and offspring", "citations": {"NLM": "Tosti G, Barberio A, Tartaglione L, Rizzi A, Di Leo M, Viti L, Sirico A, De Carolis S, Pontecorvi A, Lanzone A, Pitocco D. Lights and shadows on the use of metformin in pregnancy: from the preconception phase to breastfeeding and beyond Front Endocrinol (Lausanne). 2023;14():1176623. PMID: 37409227", "BibTeX": "@article{37409227, title={Lights and shadows on the use of metformin in pregnancy: from the preconception phase to breastfeeding and beyond}, author={Tosti G and Barberio A and Tartaglione L and Rizzi A and Di Leo M and Viti L and Sirico A and De Carolis S and Pontecorvi A and Lanzone A and Pitocco D}, journal={Front Endocrinol (Lausanne)}, volume={14}, pages={1176623}}"}}, {"_id": "32052203", "pmid": 32052203, "title": "Novel Interventions for the Prevention of Preeclampsia.", "journal": "Curr Hypertens Rep", "authors": ["Ma'ayeh M", "Rood KM", "Kniss D", "Costantine MM"], "date": "2020-02-12T00:00:00Z", "doi": "10.1007/s11906-020-1026-8", "meta_date_publication": "2020 Feb 12", "meta_volume": "22", "meta_issue": "2", "meta_pages": "17", "score": 50261.22, "text_hl": "The use of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ has also gained popularity in experimental studies, but observations from randomized clinical trials were not consistent on its utility as a possible intervention for @<m>DISEASE_Pre_Eclampsia</m> @DISEASE_MESH:D011225 @@@preeclampsia@@@ prevention. ", "citations": {"NLM": "Ma'ayeh M, Rood KM, Kniss D, Costantine MM. Novel Interventions for the Prevention of Preeclampsia. Curr Hypertens Rep. 2020 Feb 12;22(2):17. PMID: 32052203", "BibTeX": "@article{32052203, title={Novel Interventions for the Prevention of Preeclampsia.}, author={Ma'ayeh M and Rood KM and Kniss D and Costantine MM}, journal={Curr Hypertens Rep}, volume={22}, number={2}, pages={17}}"}}, {"_id": "35130922", "pmid": 35130922, "pmcid": "PMC8819934", "title": "Pregnancy, perinatal and childhood outcomes in women with and without polycystic ovary syndrome and metformin during pregnancy: a nationwide population-based study", "journal": "Reprod Biol Endocrinol", "authors": ["Fornes R", "Simin J", "Nguyen MH", "Cruz G", "Crisosto N", "van der Schaaf M", "Engstrand L", "Brusselaers N"], "date": "2022-02-07T00:00:00Z", "doi": "10.1186/s12958-022-00905-6", "meta_date_publication": "2022 Feb 7", "meta_volume": "20", "meta_issue": "1", "meta_pages": "30", "score": 50260.37, "text_hl": "To evaluate the risk of @<m>DISEASE_Pre_Eclampsia</m> @DISEASE_MESH:D011225 @@@preeclampsia@@@ and @DISEASE_Diabetes_Gestational @DISEASE_MESH:D016640 @@@gestational diabetes@@@, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@-exposure was defined as >= one prescription before week 24.", "citations": {"NLM": "Fornes R, Simin J, Nguyen MH, Cruz G, Crisosto N, van der Schaaf M, Engstrand L, Brusselaers N. Pregnancy, perinatal and childhood outcomes in women with and without polycystic ovary syndrome and metformin during pregnancy: a nationwide population-based study Reprod Biol Endocrinol. 2022 Feb 7;20(1):30. PMID: 35130922", "BibTeX": "@article{35130922, title={Pregnancy, perinatal and childhood outcomes in women with and without polycystic ovary syndrome and metformin during pregnancy: a nationwide population-based study}, author={Fornes R and Simin J and Nguyen MH and Cruz G and Crisosto N and van der Schaaf M and Engstrand L and Brusselaers N}, journal={Reprod Biol Endocrinol}, volume={20}, number={1}, pages={30}}"}}, {"_id": "34551918", "pmid": 34551918, "pmcid": "PMC8457042", "title": "Use of metformin to prolong gestation in preterm pre-eclampsia: randomised, double blind, placebo controlled trial ", "journal": "BMJ", "authors": ["Cluver CA", "Hiscock R", "Decloedt EH", "Hall DR", "Schell S", "Mol BW", "Brownfoot F", "Kaitu'u-Lino TJ", "Walker SP", "Tong S"], "date": "2021-09-22T00:00:00Z", "doi": "10.1136/bmj.n2103", "meta_date_publication": "2021 Sep 22", "meta_volume": "374", "meta_issue": "", "meta_pages": "n2103", "score": 50260.215, "text_hl": "Use of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ to prolong gestation in @<m>DISEASE_Pre_Eclampsia</m> @DISEASE_MESH:D011225 @@@preterm pre-eclampsia@@@: randomised, double blind, placebo controlled trial ", "citations": {"NLM": "Cluver CA, Hiscock R, Decloedt EH, Hall DR, Schell S, Mol BW, Brownfoot F, Kaitu'u-Lino TJ, Walker SP, Tong S. Use of metformin to prolong gestation in preterm pre-eclampsia: randomised, double blind, placebo controlled trial  BMJ. 2021 Sep 22;374():n2103. PMID: 34551918", "BibTeX": "@article{34551918, title={Use of metformin to prolong gestation in preterm pre-eclampsia: randomised, double blind, placebo controlled trial }, author={Cluver CA and Hiscock R and Decloedt EH and Hall DR and Schell S and Mol BW and Brownfoot F and Kaitu'u-Lino TJ and Walker SP and Tong S}, journal={BMJ}, volume={374}, pages={n2103}}"}}]}